Platelet activating factor and pentoxifylline as human sperm cryoprotectants

Area of Science:

• Reproductive Biology
• Cryobiology
• Sperm Preservation

Background:

• Cryopreservation of sperm is crucial for assisted reproductive technologies.
• Optimizing sperm recovery post-thaw is essential for successful outcomes.
• The role of specific additives in enhancing sperm cryosurvival requires further investigation.

Purpose of the Study:

• To evaluate the efficacy of platelet-activating factor (PAF) and pentoxifylline as cryoprotectants for human sperm.
• To determine the impact of PAF and pentoxifylline on sperm motility, viability, and motion characteristics post-thaw.
• To investigate the potential role of cyclic adenosine monophosphate (cAMP) in mediating the cryoprotective effects.

Main Methods:

• Human sperm samples were cryopreserved with and without PAF or pentoxifylline.
• Post-thaw sperm were analyzed for motility, viability, and motion parameters before and after washing.
• Intracellular cAMP concentrations were measured in treated and untreated samples.

Main Results:

• Both PAF and pentoxifylline significantly improved the recovery of motile sperm compared to controls.
• PAF increased motile sperm recovery by 38%, and pentoxifylline by 15%.
• PAF enhanced sperm linearity and velocity, while pentoxifylline improved lateral head displacement; both increased sperm viability and cAMP levels.

Conclusions:

• PAF and pentoxifylline are effective cryoprotectants for improving motile, viable sperm recovery.
• The cryoprotective effect of pentoxifylline is associated with increased cAMP levels.
• The mechanism of PAF's cryoprotective action does not appear to be mediated by elevated cAMP levels.